Standards Comparison

    FDA 21 CFR Part 11

    Mandatory
    1997

    FDA regulation equating electronic records to paper equivalents

    VS

    23 NYCRR 500

    Mandatory
    2017

    NY regulation for financial services cybersecurity

    Quick Verdict

    FDA 21 CFR Part 11 ensures electronic records/signatures trust for life sciences, while 23 NYCRR 500 mandates broad cybersecurity for NY financial firms. Pharma adopts Part 11 for FDA compliance; banks use 500 to avoid DFS fines and protect NPI.

    Electronic Records

    FDA 21 CFR Part 11

    21 CFR Part 11 Electronic Records; Electronic Signatures

    Cost
    €€€€
    Complexity
    Medium
    Implementation Time
    18-24 months

    Key Features

    • Establishes electronic records/signatures equivalent to paper/handwritten
    • Mandates secure, time-stamped audit trails for changes
    • Requires unique, non-repudiable electronic signatures with manifestation
    • Differentiates controls for closed vs. open systems
    • Enforces validation, access limits, and authority checks
    Financial Services

    23 NYCRR 500

    23 NYCRR Part 500 Cybersecurity Regulation

    Cost
    €€€€
    Complexity
    High
    Implementation Time
    18-24 months

    Key Features

    • Annual CEO/CISO dual compliance certification
    • 72-hour cybersecurity incident notification to NYDFS
    • Phishing-resistant MFA for privileged/remote access
    • Risk-based TPSP security policy and contracts
    • Annual penetration testing and vulnerability management

    Detailed Analysis

    A comprehensive look at the specific requirements, scope, and impact of each standard.

    FDA 21 CFR Part 11 Details

    What It Is

    FDA 21 CFR Part 11 is a U.S. regulation establishing criteria for electronic records and electronic signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. It applies to FDA-regulated industries using electronic systems for predicate-rule records. The risk-based approach narrows scope to relied-upon electronic records, with enforcement discretion for validation, audit trails, retention, and copies per 2003 guidance.

    Key Components

    • **Subpart BControls for closed (§11.10) and open (§11.30) systems, including validation, audit trails, access limits, checks, signatures manifestation/linking.
    • **Subpart CElectronic signature requirements (§§11.50-11.300) for uniqueness, multi-component controls, non-repudiation.
    • Core principles: authenticity, integrity, confidentiality, accountability. No fixed control count; focuses on 11+ key controls like training, policies.
    • Compliance via self-assessment, FDA inspection; no third-party certification.

    Why Organizations Use It

    Mandated for life sciences using electronic records; ensures data integrity for inspections, avoids warning letters. Benefits: inspection readiness, quality decisions, efficiency. Builds trust, reduces recalls, supports digital transformation.

    Implementation Overview

    Risk-based: scope records, classify systems, validate (CSV/IQ/OQ/PQ), implement controls, train, SOPs. Applies to pharma, devices, biotech; phased (6-24+ months). FDA audits via inspections.

    23 NYCRR 500 Details

    What It Is

    23 NYCRR Part 500 is the New York Department of Financial Services (NYDFS) Cybersecurity Regulation, a prescriptive state-level mandate for financial services entities. It establishes minimum risk-based cybersecurity requirements to protect nonpublic information (NPI) and ensure operational integrity, applying to Covered Entities like banks, insurers, and mortgage firms licensed in New York.

    Key Components

    • 14 core requirements including cybersecurity program, CISO governance, MFA, encryption, TPSP oversight, penetration testing, and 72-hour incident reporting.
    • Risk-based approach with annual assessments, dual CEO/CISO certification by April 15, and five-year record retention.
    • Enhanced rules for Class A Companies (e.g., >$20M NY revenue, >2,000 employees) like independent audits and EDR.

    Why Organizations Use It

    • Mandatory compliance avoids multimillion-dollar fines (e.g., Robinhood $30M).
    • Reduces cyber risk, improves resilience, and builds stakeholder trust.
    • Aligns with enterprise risk management for competitive edge.

    Implementation Overview

    • Phased roadmap: gap analysis, asset inventory, MFA rollout, TPSP contracts, testing.
    • Applies to NY-licensed financial entities; no certification but annual filing and DFS examinations.

    Key Differences

    Scope

    FDA 21 CFR Part 11
    Electronic records/signatures trustworthiness
    23 NYCRR 500
    Broad cybersecurity program and NPI protection

    Industry

    FDA 21 CFR Part 11
    Life sciences, pharma, medical devices (US)
    23 NYCRR 500
    NY financial services entities (state-specific)

    Nature

    FDA 21 CFR Part 11
    Mandatory FDA regulation with enforcement discretion
    23 NYCRR 500
    Mandatory state regulation with active enforcement

    Testing

    FDA 21 CFR Part 11
    Risk-based system validation (IQ/OQ/PQ)
    23 NYCRR 500
    Annual pen testing, bi-annual vulnerability scans

    Penalties

    FDA 21 CFR Part 11
    Warning letters, product holds, CGMP violations
    23 NYCRR 500
    Multi-million fines, consent orders, license actions

    Frequently Asked Questions

    Common questions about FDA 21 CFR Part 11 and 23 NYCRR 500

    FDA 21 CFR Part 11 FAQ

    23 NYCRR 500 FAQ

    You Might also be Interested in These Articles...

    Run Maturity Assessments with GRADUM

    Transform your compliance journey with our AI-powered assessment platform

    Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.

    100+ Standards & Regulations
    AI-Powered Insights
    Collaborative Assessments
    Actionable Recommendations

    Check out these other Gradum.io Standards Comparison Pages